ADTHYZA (THYROID TABLETS, USP)

Serial Number 97538981
Registration 7116955
700

Registration Progress

Application Filed
Aug 8, 2022
Under Examination
Apr 11, 2023
Approved for Publication
Feb 14, 2023
Published for Opposition
Feb 14, 2023
Registered
Jul 18, 2023

Trademark Image

ADTHYZA (THYROID TABLETS, USP)

Basic Information

Serial Number
97538981
Registration Number
7116955
Filing Date
August 8, 2022
Registration Date
July 18, 2023
Published for Opposition
February 14, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 18, 2023
Registration
Registered
Classes
005

Rights Holder

Azurity Pharmaceuticals, Inc.

03
Address
8 Cabot Road, Suite 2000
Woburn, MA 01801

Ownership History

Azurity Pharmaceuticals, Inc.

Original Applicant
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Owner at Publication
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Original Registrant
03
Woburn, MA

Legal Representation

Attorney
Elizabeth Fox

USPTO Deadlines

Next Deadline
1447 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-07-18)
Due Date
July 18, 2029
Grace Period Ends
January 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

18 events
Date Code Type Description Documents
Mar 19, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jul 18, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 18, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 16, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 15, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 23, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 22, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 1, 2023 IUAF S USE AMENDMENT FILED Loading...
May 1, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 11, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 14, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 14, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 25, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 11, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 10, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 30, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 28, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 11, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of hypothyroidism
First Use Anywhere: Feb 21, 2023
First Use in Commerce: Feb 21, 2023

Additional Information

Design Mark
The mark consists of two adjacent rounded triangle shapes with an ombre effect from teal to dark green, to the left of the word "ADTHYZA" in dark green, with the triangle shapes and capital "A" underlined with a bold purple line, and the words "(thyroid tablets, USP)" in purple underneath the word "ADTHYZA".
Color Claim
The color(s) teal, dark green, and purple is/are claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THYROID TABLETS, USP"